Skip to main content

Table 1 Plasmids and primers used in the present study

From: Characterization of the hupSL promoter activity in Nostoc punctiformeATCC 29133

Plasmids

Reporter gene

Reference

pSUN202

gfp

(2)

pA-gfp

gfp

This study

pB-gfp

gfp

This study

pC-gfp

gfp

This study

pD-gfp

gfp

This study

pE-gfp

gfp

This study

pPprbcL-gfp

gfp

This study

pLR1

luxAB

P Lindberg, unpublished

pA-lux

luxAB

This study

pB-lux

luxAB

This study

pC-lux

luxAB

This study

pD-lux

luxAB

This study

pE-lux

luxAB

This study

pPprbc-Llux

luxAB

This study

Primers

Sequence 5'-3'

Restriction site

GFP

  

CLONING

  

A GFP forward

CGCGGTACCAGGCTTCGAGTCCTTTAGGC

KpnI

B GFP forward

CGCGGTACCTCAATCCCCTAAATTG

KpnI

C GFP forward

CGCGGTACCTTCTAAAATTCTAGGGGGAAATTG

KpnI

D GFP forward

CGCGGTACCGACCTGACACAACGCAGTTC

KpnI

E GFP forward

CGCGGTACCTCACCTTTAAAATCTTAGCCCATT

KpnI

PhupS GFP reverse 1

CGCGAATTCGGGCTAGGTGTTTTTGTATTGT

EcoRI

PhupS GFP reverse 2

CGCCAATTGGGGCTAGGTGTTTTTGTATTGT

MunI

PprbcL GFP forward

CGCGGTACCATCGGGCAAGGATTCT

KpnI

PprbcL GFP reverse

CGCGCAATTGATTTTATCCTTCCCTGAAAT

MunI

CONFIRMATION

  

pSUN202 seq primer forward

CAAGTAGCGAAGCGAGCAG

-

pSUN202 seq primer reverse

TGGGACAACTCCAGTGAAAA

-

LUCIFERASE

  

CLONING

  

A lux forward

CATCTCGTAGGCCCGGTAAT

-

B lux forward

GCGCGAATTCTCAATCCCCTAAATTG

EcoRI

C lux forward

GCGCGAATTCTAAAATTCTAGGGGGAAATTG

EcoRI

D lux forward

GCGCGAATTCGACCTGACACAACGCAGTTC

EcoRI

E lux forward

GCGCGAATTCACCTTTAAAATCTTAGCCCATT

EcoRI

PhupS lux reverse

GCGCGGTACCGGGCTAGGTGTTTTTGTATTGT

KpnI

Pprbc lux forward

GCGCCAATTGCATCGGGCAAGGATTCT

MunI

Pprbc lux reverse

GCGCGGTACCGGCTTGATACCCAGACTTGC

KpnI

CONFIRMATION

  

pLR1 seq forward

AATACCGCACAGATGCGTAA

-

pLR1 seq reverse

CCAATTAGCGAATAGAGCTT

-

EMSA

  

GS forward

GCGCGAATTCCCAATACCTAATACTTAATCCTC

-

GS reverse

GCGCTCTAGATAACAAAGTTAGGTCTTAA

-

  1. Plasmids and primer oligonucleotides designed and used to amplify DNA fragments by PCR for vector construction, confirmation, and generation of cloned promoter fragments. Oligonucleotides designed and used for EMSAs are also shown. Restriction sites inserted in the cloning primers are listed.